Literature DB >> 2923516

Postoperative changes in serum creatinine. When do they occur and how much is important?

M E Charlson1, C R MacKenzie, J P Gold, G T Shires.   

Abstract

The objective of this study was to evaluate the use of the serum creatinine in following postoperative renal function. In this prospective study of 278 patients (mainly hypertensives and diabetics) undergoing noncardiac surgery, the serum creatinines were followed from the first through the sixth postoperative day. Creatinine clearances were evaluated before operation and on the fourth to fifth postoperative day. During the first six days after the operation, 23% (65 of 278 patients) had an increase of serum creatinine greater than or equal to 20%. Such increases were sustained for greater than or equal to 48 hours in 12% of the patients (32 of 278), and half of these patients had not returned to their initial level of renal function by the time of discharge. Patients who sustained such a deterioration were at risk for nonoliguric renal failure if they had a subsequent insult (i.e., hypotension, reoperation, angiography, aminoglycosides). Such increases occurred early in the postoperative period--on the first or second postoperative day. As judged by the creatinine clearances, postoperative increases of greater than or equal to 20% in the serum creatinine identified most patients whose clearance fell more than 50%, although the serum creatinine did not accurately reflect changes in creatinine clearance among those patients who had undergone an amputation. It is concluded that the serum creatinine is useful in monitoring postoperative renal function. Of those patients who had postoperative increases in serum creatinine sustained for greater than or equal to 48 hours, as many as one third had evidence of impairment in renal function at the time of discharge.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923516      PMCID: PMC1493940          DOI: 10.1097/00000658-198903000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  34 in total

Review 1.  Use of serum creatinine concentrations to determine renal function.

Authors:  T D Bjornsson
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

2.  Risks of general anesthesia and elective operation in the hypertensive patient.

Authors:  L Goldman; D L Caldera
Journal:  Anesthesiology       Date:  1979-04       Impact factor: 7.892

3.  Correction of the renal hemodynamic changes produced by surgical trauma.

Authors:  K Eng; W M Stahl
Journal:  Ann Surg       Date:  1971-07       Impact factor: 12.969

4.  Clinical assessment of glomerular filtration rate by different forms of creatinine clearance and a modified urinary phenolsulphonphthalein excretion test.

Authors:  J K Healy
Journal:  Am J Med       Date:  1968-03       Impact factor: 4.965

5.  Prophylactic diuresis with ethacrynic acid for prevention of postoperative renal failure.

Authors:  W M Stahl; A M Stone
Journal:  Ann Surg       Date:  1970-09       Impact factor: 12.969

6.  Workup bias in prediction research.

Authors:  R J Panzer; A L Suchman; P F Griner
Journal:  Med Decis Making       Date:  1987 Apr-Jun       Impact factor: 2.583

7.  Urinary diagnostic indices in acute renal failure: a prospective study.

Authors:  T R Miller; R J Anderson; S L Linas; W L Henrich; A S Berns; P A Gabow; R W Schrier
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

8.  Prevention of functional renal failure during anesthesia and surgery by sustained hydration and mannitol infusion.

Authors:  R I Mazze; K G Barry
Journal:  Anesth Analg       Date:  1967 Jan-Feb       Impact factor: 5.108

9.  Prediction of lean body mass from height and weight.

Authors:  R Hume
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

10.  Renal function and stress response during halothane or fentanyl anesthesia.

Authors:  K Kono; D M Philbin; C H Coggins; J Moss; C E Rosow; R C Schneider; E E Slater
Journal:  Anesth Analg       Date:  1981-08       Impact factor: 5.108

View more
  6 in total

1.  Inclusion of a nitric oxide congener in the insufflation gas repletes S-nitrosohemoglobin and stabilizes physiologic status during prolonged carbon dioxide pneumoperitoneum.

Authors:  Kazufumi Shimazutsu; Kenichiro Uemura; Kathryn M Auten; Matthew F Baldwin; Samuel W Belknap; Francisco La Banca; Maximilian C Jones; Deborah J McClaine; Rebecca J McClaine; W Steve Eubanks; Jonathan S Stamler; James D Reynolds
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

2.  Incidence, risk factors and prognosis of changes in serum creatinine early after aortic abdominal surgery.

Authors:  Christoph Ellenberger; Alexandre Schweizer; John Diaper; Afksendiyos Kalangos; Nicolas Murith; Gregory Katchatourian; Aristote Panos; Marc Licker
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

3.  Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications?

Authors:  M E Charlson; C R MacKenzie; J P Gold; K L Ales; M Topkins; G T Shires
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

4.  Preoperative characteristics predicting intraoperative hypotension and hypertension among hypertensives and diabetics undergoing noncardiac surgery.

Authors:  M E Charlson; C R MacKenzie; J P Gold; K L Ales; M Topkins; G T Shires
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

5.  The efficacy and safety of a pharmacologic protocol for maintaining coronary artery bypass patients at a higher mean arterial pressure during cardiopulmonary bypass. 1998.

Authors:  P A Pirraglia; J C Peterson; G S Hartman; F S Yao; S J Thomas; M E Charlson
Journal:  J Extra Corpor Technol       Date:  2013-09

6.  Analysis of risk factors for perioperative complications in spine surgery.

Authors:  Nicole Lange; Thomas Stadtmüller; Stefanie Scheibel; Gerda Reischer; Arthur Wagner; Bernhard Meyer; Jens Gempt
Journal:  Sci Rep       Date:  2022-08-23       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.